| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Alfred S L Cheng | |
| Daisy P F Tsang | |||
| P2860 | cites work | Combined epigenetic therapy with the histone methyltransferase EZH2 inhibitor 3-deazaneplanocin A and the histone deacetylase inhibitor panobinostat against human AML cells | Q34994576 |
| Roles of the EZH2 histone methyltransferase in cancer epigenetics | Q37250591 | ||
| Notch1 signaling sensitizes tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human hepatocellular carcinoma cells by inhibiting Akt/Hdm2-mediated p53 degradation and up-regulating p53-dependent DR5 expression | Q37269259 | ||
| Unique polycomb gene expression pattern in Hodgkin's lymphoma and Hodgkin's lymphoma-derived cell lines | Q38704458 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 19-27 | |
| P577 | publication date | 2011-01-01 | |
| P1433 | published in | Journal of Gastroenterology and Hepatology | Q15764401 |
| P1476 | title | Epigenetic regulation of signaling pathways in cancer: role of the histone methyltransferase EZH2. | |
| P478 | volume | 26 |
| Q43964385 | Alliance of epigenetic forces for the activation of oncogenic Wnt/β-catenin signaling. |
| Q38931043 | BAZ2A (TIP5) is involved in epigenetic alterations in prostate cancer and its overexpression predicts disease recurrence |
| Q34287662 | Cancer genetics and epigenetics: two sides of the same coin? |
| Q33988586 | Carboxyl-terminal truncated HBx regulates a distinct microRNA transcription program in hepatocellular carcinoma development |
| Q34195077 | Current limitations and future opportunities for epigenetic therapies. |
| Q90446190 | DZNep inhibits Hif-1α and Wnt signalling molecules to attenuate the proliferation and invasion of BGC-823 gastric cancer cells |
| Q36237945 | DZNep inhibits the proliferation of colon cancer HCT116 cells by inducing senescence and apoptosis |
| Q28072419 | Development of New Molecular EZH2 on Lung Cancer Invasion and Metastasis |
| Q28554315 | Dietary Flavones as Dual Inhibitors of DNA Methyltransferases and Histone Methyltransferases |
| Q36885677 | Differential microRNA profiles and their functional implications in different immunogenetic subsets of chronic lymphocytic leukemia |
| Q36861707 | EZH2 is required for breast and pancreatic cancer stem cell maintenance and can be used as a functional cancer stem cell reporter. |
| Q37472017 | EZH2 protein expression associates with the early pathogenesis, tumor progression, and prognosis of non-small cell lung carcinoma |
| Q38626547 | EZH2 silencing with RNA interference induces G2/M arrest in human lung cancer cells in vitro |
| Q36099282 | EZH2 silencing with RNAi enhances irradiation-induced inhibition of human lung cancer growth in vitro and in vivo |
| Q53273169 | Effects of four single nucleotide polymorphisms of EZH2 on cancer risk: a systematic review and meta-analysis. |
| Q36217858 | Enhancer of zeste homologue 2 (EZH2) is a reliable immunohistochemical marker to differentiate malignant and benign hepatic tumors. |
| Q38837858 | Epigenetic Determinants of Cancer |
| Q38058972 | Epigenetic alterations involved in cancer stem cell reprogramming |
| Q41973340 | Epigenetic changes in colorectal cancer |
| Q34129835 | Epigenetic modifications by dietary phytochemicals: implications for personalized nutrition |
| Q38723183 | Epigenetic silencing and activation of transcription: influence on the radiation sensitivity of glioma cell lines |
| Q27331953 | Focused examination of the intestinal epithelium reveals transcriptional signatures consistent with disturbances in enterocyte maturation and differentiation during the course of SIV infection |
| Q30830033 | Functional brain imaging in gastroenterology: to new beginnings |
| Q35189387 | HOXA11 gene is hypermethylation and aberrant expression in gastric cancer |
| Q37571496 | Hepatoepigenetic Alterations in Viral and Nonviral-Induced Hepatocellular Carcinoma. |
| Q39078089 | Immunoaffinity enrichment and mass spectrometry analysis of protein methylation |
| Q41141922 | In silico finding of Putative Cis-Acting Elements for the Tethering of Polycomb Repressive Complex2 in Human Genome. |
| Q36544065 | Inhibition of EZH2 suppresses self-renewal and induces radiation sensitivity in atypical rhabdoid teratoid tumor cells |
| Q38337958 | Interaction of sonic hedgehog (SHH) pathway with cancer stem cell genes in gastric cancer |
| Q47912856 | Involvement of aberrantly expressed microRNAs in the pathogenesis of head and neck squamous cell carcinoma. |
| Q35727617 | Involvement of enhancer of zeste homolog 2 in cisplatin-resistance in ovarian cancer cells by interacting with several genes |
| Q64079033 | JARID1B expression and its function in DNA damage repair are tightly regulated by miRNAs in breast cancer |
| Q49201007 | KDM2B overexpression correlates with poor prognosis and regulates glioma cell growth |
| Q37576353 | Long non-coding RNA TUG1 is involved in cell growth and chemoresistance of small cell lung cancer by regulating LIMK2b via EZH2. |
| Q89542605 | Loss of tumor suppressor IGFBP4 drives epigenetic reprogramming in hepatic carcinogenesis |
| Q33648797 | Methylation-mediated silencing of microRNA-211 promotes cell growth and epithelial to mesenchymal transition through activation of the AKT/β-catenin pathway in GBM |
| Q33875597 | Metronomic docetaxel in PRINT nanoparticles and EZH2 silencing have synergistic antitumor effect in ovarian cancer |
| Q28551027 | MiR-138 Acts as a Tumor Suppressor by Targeting EZH2 and Enhances Cisplatin-Induced Apoptosis in Osteosarcoma Cells |
| Q48168117 | MicroRNA-137 is negatively associated with clinical outcome and regulates tumor development through EZH2 in cervical cancer. |
| Q36394758 | MicroRNA-98 and microRNA-214 post-transcriptionally regulate enhancer of zeste homolog 2 and inhibit migration and invasion in human esophageal squamous cell carcinoma |
| Q52593633 | Migration/Invasion of Malignant Gliomas and Implications for Therapeutic Treatment. |
| Q38045799 | Non-coding RNAs and EZH2 interactions in cancer: long and short tales from the transcriptome. |
| Q90641275 | PIWI-interacting RNAs: new biomarkers for diagnosis and treatment of breast cancer |
| Q37934740 | Piwis and piwi-interacting RNAs in the epigenetics of cancer |
| Q36105152 | Polycomb group protein EZH2-mediated E-cadherin repression promotes metastasis of oral tongue squamous cell carcinoma |
| Q28393302 | Potential epigenetic mechanism(s) associated with the persistence of psychoneurological symptoms in women receiving chemotherapy for breast cancer: a hypothesis |
| Q34451033 | Promotion of glioblastoma cell motility by enhancer of zeste homolog 2 (EZH2) is mediated by AXL receptor kinase |
| Q35148549 | Quantitative nuclear proteomics identifies that miR-137-mediated EZH2 reduction regulates resveratrol-induced apoptosis of neuroblastoma cells |
| Q34769837 | Regulation of gene expression in HBV- and HCV-related hepatocellular carcinoma: integrated GWRS and GWGS analyses |
| Q37628541 | Regulation of hepatic microRNA expression by hepatocyte nuclear factor 4 alpha |
| Q38836700 | Retinoic acid‑incorporated glycol chitosan nanoparticles inhibit the expression of Ezh2 in U118 and U138 human glioma cells |
| Q57107504 | Role for Growth Regulation by Estrogen in Breast Cancer 1 (GREB1) in Hormone-Dependent Cancers |
| Q33914216 | Role of EZH2 in cancer stem cells: from biological insight to a therapeutic target |
| Q37565797 | Semiconductor-based DNA sequencing of histone modification states |
| Q92572430 | Silencing of microRNA-708 promotes cell growth and epithelial-to-mesenchymal transition by activating the SPHK2/AKT/β-catenin pathway in glioma |
| Q38707876 | Targeting epigenetic regulators for cancer therapy: modulation of bromodomain proteins, methyltransferases, demethylases, and microRNAs |
| Q36032753 | Targeting the enhancer of zeste homologue 2 in medulloblastoma. |
| Q28083829 | The critical role of Akt in cardiovascular function |
| Q42366629 | The histone methyltransferase EZH2 as a druggable target in SHH medulloblastoma cancer stem cells |
| Q38241688 | The potential role of O-GlcNAc modification in cancer epigenetics. |
| Q38244904 | The role of catecholamines in mesenchymal stem cell fate. |
| Q38271374 | The role of polycomb repressive complexes in biliary tract cancer. |
| Q89456266 | lncRNA PVT1 accelerates progression of non-small cell lung cancer via targeting miRNA-526b/EZH2 regulatory loop |
Search more.